Protective effect of saxagliptin against renal ischaemia reperfusion injury in rats

Arch Physiol Biochem. 2022 Jun;128(3):608-618. doi: 10.1080/13813455.2020.1715442. Epub 2020 Jan 24.

Abstract

Saxagliptin is an effective and selective dipeptidyl peptidase-4 (DPP-4) inhibitor. This study was designed to determine possible protective effects of saxagliptin against damage caused by renal ischaemia/reperfusion (I/R) in rats. In this study, 40 rats were divided into 4 groups (n = 10 for each). Group 1 (Control), Group 2 (I/R) in both kidneys ischaemia of 45 min was performed, and then reperfusion was applied for 24 h. Saxagliptin (Group 3: 2 mg/kg and Group 4: 10 mg/kg) was administered by oral gavage to the animals in treatment groups, before the I/R. Saxagliptin decreased the markers (BUN, Cre, NGAL, KIM-1 and IL-18) of acute renal damage in blood and kidney tissue. Saxagliptin provided increase in antioxidant enzyme levels and decrease in MDA and apoptosis. Histological results showed that the administration of saxagliptin exhibited a protective effect against renal damage caused by I/R. These results indicates that saxagliptin provide protection against kidney injury caused by I/R.

Keywords: Dipeptidyl peptidase-4 inhibitor; lipid peroxidation; oxidative stress; renal ischaemia reperfusion; saxagliptin.

MeSH terms

  • Adamantane* / analogs & derivatives
  • Adamantane* / pharmacology
  • Adamantane* / therapeutic use
  • Animals
  • Dipeptides / pharmacology
  • Dipeptides / therapeutic use
  • Kidney
  • Kidney Diseases* / pathology
  • Rats
  • Reperfusion Injury* / pathology
  • Reperfusion Injury* / prevention & control

Substances

  • Dipeptides
  • saxagliptin
  • Adamantane